Overview

18F-S16 PET/CT in Healthy Volunteers and Patients With Neurodegenerative Dementia

Status:
Unknown status
Trial end date:
2019-02-20
Target enrollment:
Participant gender:
Summary
This is an open-label dynamic whole-body PET/CT (positron emission tomography/computed tomography) study for investigation of radiation dosimetry, plasma pharmacokinetics, biodistribution, safety and diagnostic performance of 18F-S16 in healthy volunteers and patients with neurodegenerative dementia.
Phase:
Early Phase 1
Details
Lead Sponsor:
Oriental Neurosurgery Evidence-Based-Study Team